Publicaciones en colaboración con investigadores/as de Hospital del Mar (257)

2024

  1. Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort

    Critical Care, Vol. 28, Núm. 1

  2. Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial

    Haematologica, Vol. 109, Núm. 2, pp. 543-552

  3. Impact of an antimicrobial stewardship program indicator on the appropriateness of the empiric antibiotic treatment of urinary source Escherichia coli bacteraemia

    International Journal of Antimicrobial Agents, Vol. 64, Núm. 2

  4. Long-term survival after cardiac arrest in patients undergoing emergent coronary angiography

    Cardiovascular Revascularization Medicine, Vol. 60, pp. 18-26

  5. Real-world adalimumab survival and discontinuation factors in hidradenitis suppurativa

    Journal of the European Academy of Dermatology and Venereology

  6. Role of Advanced Glycation End Products as New Biomarkers in Systemic Lupus Erythematosus

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

  7. Therapeutic outcomes and survival analysis of Extramammary Paget's disease: A multicentre retrospective study of 249 patients

    Journal of the American Academy of Dermatology, Vol. 90, Núm. 1, pp. 66-73

  8. “For and against” factors influencing participation in personalized breast cancer screening programs: a qualitative systematic review until March 2022

    Archives of Public Health, Vol. 82, Núm. 1

2023

  1. A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

    Respiratory Research, Vol. 24, Núm. 1

  2. Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study

    European Archives of Psychiatry and Clinical Neuroscience

  3. Association of Serum Neurofilament Light Chain Levels at Disease Onset with Disability Worsening in Patients with a First Demyelinating Multiple Sclerosis Event Not Treated with High-Efficacy Drugs

    JAMA Neurology, Vol. 80, Núm. 4, pp. 397-403

  4. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

  5. Effect of Perioperative Blood Transfusions and Infectious Complications on Inflammatory Activation and Long-Term Survival Following Gastric Cancer Resection

    Cancers, Vol. 15, Núm. 1

  6. Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis

    The European respiratory journal, Vol. 61, Núm. 3

  7. Emergency department admissions and economic costs burden related to ambulatory care sensitive conditions in older adults living in care homes

    Revista Clinica Espanola, Vol. 223, Núm. 10, pp. 585-595

  8. Evolution of quality indicators in acute stroke during the RACECAT Trial: Impact in the general population

    International Journal of Stroke, Vol. 18, Núm. 2, pp. 229-236

  9. First pass effect in posterior circulation occlusions: Analysis from the CICAT registry

    International Journal of Stroke, Vol. 18, Núm. 2, pp. 221-228

  10. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  11. Lipidomic signature of stroke recurrence after transient ischemic attack

    Scientific Reports, Vol. 13, Núm. 1

  12. Medical help-seeking intentions among patients with early Alzheimer’s disease

    Frontiers in Psychiatry, Vol. 14